{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:07:57Z","timestamp":1794377277069,"version":"4.9.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek Vlaanderen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.critrevonc.2024.104285","type":"journal-article","created":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T00:15:27Z","timestamp":1706919327000},"page":"104285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["A systematic review of patient-derived tumor organoids generation from malignant effusions"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2438-4155","authenticated-orcid":false,"given":"Sofie","family":"Seghers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"Le Compte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen M.H.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Van Schil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinier","family":"Wener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Komen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Prenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Deben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"47","key":"10.1016\/j.critrevonc.2024.104285_bib1","doi-asserted-by":"crossref","first-page":"29227","DOI":"10.1039\/D1RA03820F","article-title":"CDK4\/6 inhibitors: a brief overview and prospective research directions","volume":"11","author":"Adon","year":"2021","journal-title":"RSC Adv."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104285_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1074\/mcp.M300127-MCP200","article-title":"The human plasma proteome: a nonredundant list developed by combination of four separate sources","volume":"3","author":"Anderson","year":"2004","journal-title":"Mol. Cell Proteom."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104285_bib3","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/annonc\/mdl499","article-title":"Pattern and prognostic factors in patients with malignant ascites: a retrospective study","volume":"18","author":"Ayantunde","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104285_bib4","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.82998","article-title":"The role of macrophages in non-small cell lung cancer and advancements in 3D co-cultures","volume":"12","author":"Bal\u00e1\u017eov\u00e1","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.critrevonc.2024.104285_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120610","article-title":"A biomimetic model of 3D fluid extracellular macromolecular crowding microenvironment fine-tunes ovarian cancer cells dissemination phenotype","volume":"269","author":"Bascetin","year":"2021","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104285_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112539","article-title":"A prospective feasibility trial to challenge patient-derived pancreatic cancer organoids in predicting treatment response","volume":"13","author":"Beutel","year":"2021","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104285_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13122901","article-title":"Successful patient-derived organoid culture of gynecologic cancers for disease modeling and drug sensitivity testing","volume":"13","author":"Bi","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104285_bib8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13048-022-01046-5","article-title":"Using genetically encoded fluorescent biosensors to interrogate ovarian cancer metabolism","volume":"15","author":"Bose","year":"2022","journal-title":"J. Ovarian Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104285_bib9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MCP.0000000000000285","article-title":"Complications of thoracentesis: incidence, risk factors, and strategies for prevention","volume":"22","author":"Cantey","year":"2016","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104285_bib10","first-page":"3538","article-title":"A panel of markers for identification of malignant and non-malignant cells in culture from effusions","volume":"38","author":"Carneiro","year":"2017","journal-title":"Oncol. Rep."},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104285_bib11","first-page":"1169","article-title":"Molecular profiling of malignant pleural effusion in metastatic non-small-cell lung carcinoma. The effect of preanalytical factors","volume":"14","author":"Carter","year":"2017","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104285_bib12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12964-022-00991-4","article-title":"Single-cell and bulk RNA sequencing reveal ligands and receptors associated with worse overall survival in serous ovarian cancer","volume":"20","author":"Carvalho","year":"2022","journal-title":"Cell Commun. Signal"},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104285_bib13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ygyno.2020.03.026","article-title":"Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma","volume":"157","author":"Chen","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"1-2","key":"10.1016\/j.critrevonc.2024.104285_bib14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41417-020-0190-y","article-title":"An organoid-based drug screening identified a menin-MLL inhibitor for endometrial cancer through regulating the HIF pathway","volume":"28","author":"Chen","year":"2021","journal-title":"Cancer Gene Ther."},{"issue":"22","key":"10.1016\/j.critrevonc.2024.104285_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101176","article-title":"Patient-derived organoids can guide personalized-therapies for patients with advanced breast cancer","volume":"8","author":"Chen","year":"2021","journal-title":"Adv. Sci."},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104285_bib16","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling development and disease with organoids","volume":"165","author":"Clevers","year":"2016","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104285_bib17","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","article-title":"Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids","volume":"174","author":"Dijkstra","year":"2018","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104285_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107588","article-title":"Challenges in establishing pure lung cancer organoids limit their utility for personalized medicine","volume":"31","author":"Dijkstra","year":"2020","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104285_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112212","article-title":"Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma","volume":"42","author":"Ebisudani","year":"2023","journal-title":"Cell Rep."},{"issue":"23","key":"10.1016\/j.critrevonc.2024.104285_bib20","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1158\/1078-0432.CCR-21-1681","article-title":"Organoids derived from neoadjuvant FOLFIRINOX patients recapitulate therapy resistance in pancreatic ductal adenocarcinoma","volume":"27","author":"Farshadi","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104285_bib21","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1186\/s12885-019-6149-4","article-title":"Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours","volume":"19","author":"Fusco","year":"2019","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104285_bib22","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/s41591-019-0584-2","article-title":"A rectal cancer organoid platform to study individual responses to chemoradiation","volume":"25","author":"Ganesh","year":"2019","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104285_bib23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/boc.202100003","article-title":"A new pancreatic adenocarcinoma-derived organoid model of acquired chemoresistance to FOLFIRINOX: first insight of the underlying mechanisms","volume":"114","author":"Hadj Bachir","year":"2022","journal-title":"Biol. Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104285_bib24","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1038\/s41467-021-22676-1","article-title":"Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week","volume":"12","author":"Hu","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104285_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7150\/thno.90093","article-title":"Tumor-on-a-chip models combined with mini-tissues or organoids for engineering tumor tissues","volume":"14","author":"Hwangbo","year":"2024","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104285_bib26","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.actbio.2014.02.035","article-title":"Gelatine methacrylamide-based hydrogels: an alternative three-dimensional cancer cell culture system","volume":"10","author":"Kaemmerer","year":"2014","journal-title":"Acta Biomater."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104285_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1413","article-title":"R.N.A. in extracellular vesicles","volume":"8","author":"Kim","year":"2017","journal-title":"Wiley Interdiscip. Rev. RNA"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104285_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35526-w","article-title":"Evaluating tumor evolution via genomic profiling of individual tumor spheroids in a malignant ascites","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.critrevonc.2024.104285_bib29","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1158\/1078-0432.CCR-20-5026","article-title":"Modeling clinical responses to targeted therapies by patient-derived organoids of advanced lung adenocarcinoma","volume":"27","author":"Kim","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104285_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2023.100105","article-title":"Efficient establishment of bile-derived organoids from patients with biliary cancer","volume":"103","author":"Kinoshita","year":"2023","journal-title":"Lab. Investig."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104285_bib31","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","article-title":"An organoid platform for ovarian cancer captures intra-and interpatient heterogeneity","volume":"25","author":"Kopper","year":"2019","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104285_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cells10113012","article-title":"Scientific validation and clinical application of lung cancer organoids","volume":"10","author":"Lee","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104285_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ccell.2021.12.004","article-title":"Functional precision oncology: testing tumors with drugs to identify vulnerabilities and novel combinations","volume":"40","author":"Letai","year":"2022","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104285_bib34","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s00432-019-03004-z","article-title":"Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screening","volume":"145","author":"Li","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104285_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103610","article-title":"Lung cancer organoids, a promising model still with long way to go","volume":"171","author":"Ma","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104285_bib36","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1021\/acsbiomaterials.8b01356","article-title":"Pleural effusion aspirate for use in 3D lung cancer modeling and chemotherapy screening","volume":"5","author":"Mazzocchi","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104285_bib37","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1021\/acsbiomaterials.8b01356","article-title":"Pleural effusion aspirate for use in 3D lung cancer modeling and chemotherapy screening","volume":"5","author":"Mazzocchi","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"513","key":"10.1016\/j.critrevonc.2024.104285_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay2574","article-title":"Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients","volume":"11","author":"Ooft","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104285_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23520","article-title":"Establishment of a novel overlay culture method that enables immune response assessment using gastric cancer organoids","volume":"10","author":"Ota","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.critrevonc.2024.104285_bib40","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104285_bib41","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11626-021-00563-9","article-title":"Breast cancer organoids from malignant pleural effusion-derived tumor cells as an individualized medicine platform","volume":"57","author":"Pan","year":"2021","journal-title":"Vitr. Cell. Dev. Biol. Anim."},{"issue":"17","key":"10.1016\/j.critrevonc.2024.104285_bib42","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1158\/1078-0432.CCR-18-3590","article-title":"Patient-derived cancer organoid cultures to predict sensitivity to chemotherapy and radiation","volume":"25","author":"Pasch","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104285_bib43","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/1759-7714.14429","article-title":"Clinical outcomes of EGFR+\/METamp+\u2009vs. EGFR+\/METamp- untreated patients with advanced non-small cell lung cancer","volume":"13","author":"Peng","year":"2022","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.critrevonc.2024.104285_bib44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/CMAR.S95663","article-title":"Management of malignant pleural effusion: challenges and solutions","author":"Penz","year":"2017","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.critrevonc.2024.104285_bib45","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00408-017-0050-1","article-title":"Prognosis of cancer with synchronous or metachronous malignant pleural effusion","volume":"195","author":"Porcel","year":"2017","journal-title":"Lung"},{"issue":"140","key":"10.1016\/j.critrevonc.2024.104285_bib46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1183\/16000617.0019-2016","article-title":"Malignant pleural effusion: from bench to bedside","volume":"25","author":"Psallidas","year":"2016","journal-title":"Eur. Respir. Rev."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104285_bib47","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","article-title":"A living biobank of breast cancer organoids captures disease heterogeneity","volume":"172","author":"Sachs","year":"2018","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104285_bib48","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100300","article-title":"Long\u2010term expanding human airway organoids for disease modeling","volume":"38","author":"Sachs","year":"2019","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104285_bib49","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.celrep.2019.03.088","article-title":"Establishment of patient-derived organoids and drug screening for biliary tract carcinoma","volume":"27","author":"Saito","year":"2019","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104285_bib50","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00953-2019","article-title":"ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma","volume":"55","author":"Scherpereel","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.critrevonc.2024.104285_bib51","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/path.5698","article-title":"Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens","volume":"254","author":"Servant","year":"2021","journal-title":"J. Pathol."},{"key":"10.1016\/j.critrevonc.2024.104285_bib52","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/985141","article-title":"Hemorrhagic complications of paracentesis: a systematic review of the literature","volume":"2014","author":"Sharzehi","year":"2014","journal-title":"Gastroenterol. Res. Pract."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104285_bib53","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104285_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e13829","article-title":"Patient-derived spheroids and patient-derived organoids simulate evolutions of lung cancer","volume":"9","author":"Surina","year":"2023","journal-title":"Heliyon"},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104285_bib55","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1158\/0008-5472.CAN-19-3183","article-title":"Single-cell proteomic profiling identifies combined AXL and JAK1 inhibition as a novel therapeutic strategy for lung cancer","volume":"80","author":"Taverna","year":"2020","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2024.104285_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201700980","article-title":"Biomaterials\u2010based approaches to tumor spheroid and organoid modeling","volume":"7","author":"Thakuri","year":"2018","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104285_bib57","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12885-018-4238-4","article-title":"Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models","volume":"18","author":"Tsai","year":"2018","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2024.104285_bib58","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/bjs.11206","article-title":"Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy","volume":"106","author":"Ubink","year":"2019","journal-title":"Br. J. Surg."},{"issue":"4","key":"10.1016\/j.critrevonc.2024.104285_bib59","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.tiv.2010.03.016","article-title":"Optimization of chemically defined cell culture media--replacing fetal bovine serum in mammalian in vitro methods","volume":"24","author":"van der Valk","year":"2010","journal-title":"Toxicol. Vitr."},{"issue":"3","key":"10.1016\/j.critrevonc.2024.104285_bib60","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41418-021-00878-w","article-title":"Single cell-derived spheroids capture the self-renewing subpopulations of metastatic ovarian cancer","volume":"29","author":"Velletri","year":"2022","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.critrevonc.2024.104285_bib61","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.ccell.2021.07.020","article-title":"Tumor organoids: opportunities and challenges to guide precision medicine","volume":"39","author":"Veninga","year":"2021","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.critrevonc.2024.104285_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123636","article-title":"Patient-derived tumor organoids for drug repositioning in cancer care: a promising approach in the era of tailored treatment","volume":"12","author":"Vivarelli","year":"2020","journal-title":"Cancers"},{"issue":"6378","key":"10.1016\/j.critrevonc.2024.104285_bib63","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.critrevonc.2024.104285_bib64","article-title":"Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: a real-world study","volume":"4","author":"Wang","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.critrevonc.2024.104285_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-00893-3","article-title":"Non-coding RNAs shuttled via exosomes reshape the hypoxic tumor microenvironment","volume":"13","author":"Wang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2024.104285_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215735","article-title":"Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer","volume":"542","author":"Wang","year":"2022","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.critrevonc.2024.104285_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107762","article-title":"Patient-derivedovarian cancer organoids mimic clinical response and exhibit heterogeneous inter-and intrapatient drug responses","volume":"31","author":"de Witte","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.critrevonc.2024.104285_bib68","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.scr.2018.08.021","article-title":"Long-term organoid culture reveals enrichment of organoid-forming epithelial cells in the fimbrial portion of mouse fallopian tube","volume":"32","author":"Xie","year":"2018","journal-title":"Stem Cell Res."},{"issue":"7","key":"10.1016\/j.critrevonc.2024.104285_bib69","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.7150\/thno.70194","article-title":"SCD1\/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells","volume":"12","author":"Xuan","year":"2022","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104285_bib70","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","article-title":"Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer","volume":"26","author":"Yao","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2024.104285_bib71","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41698-021-00166-3","article-title":"Clinical application of a lung cancer organoid (tumoroid) culture system","volume":"5","author":"Yokota","year":"2021","journal-title":"NPJ Precis. Oncol."},{"issue":"13","key":"10.1016\/j.critrevonc.2024.104285_bib72","doi-asserted-by":"crossref","first-page":"14375","DOI":"10.1002\/cam4.5943","article-title":"Standardization of organoid culture in cancer research","volume":"12","author":"Zhou","year":"2023","journal-title":"Cancer Med."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842824000283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842824000283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:52:47Z","timestamp":1760903567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842824000283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":72,"alternative-id":["S1040842824000283"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104285","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of patient-derived tumor organoids generation from malignant effusions","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104285"}}